SIM
FOMX

Spark Investment Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Spark Investment Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-16,900
Closed -$156K – 781
2015
Q1 		$156K Sell
16,900
-75
-0.4% -$671 0.02% 576
2014
Q4 		$118K Sell
16,975
-2,925
-15% -$16.7K 0.02% 560
2014
Q3 		$109K Buy
+19,900
New +$114K 0.02% 584

Other funds holding FOMX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Spark Investment Management's FOMX Position: Q2 2015 in Review

Spark Investment Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2015, closing a stake of 16,900 shares — an estimated $156K sold.

Spark Investment Management first reported a position in FOMX in Q3 2014 and held it in 3 quarters. The position peaked at $156K in Q1 2015. 84 funds tracked by Wall St. Rank hold FOMX as of Q2 2015.

  • Spark Investment Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2015 after selling out during the quarter.
  • Spark Investment Management sold 16,900 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2015, an estimated $156K.
  • Spark Investment Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2014 and held it in 3 quarters.
  • Spark Investment Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $156K in Q1 2015.
  • 84 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2015.

Based on Spark Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.